Highlights Visioneering Technologies, Inc.

Equities

VTI

AU000000VTI2

Market Closed - Australian S.E. Other stock markets 06:28:09 16/05/2024 BST			5-day change	1st Jan Change
0.12 ^AUD	+14.29%		+20.00%	-52.00%

04-24	Transcript : Visioneering Technologies, Inc., Q1 2024 Earnings Call, Apr 23, 2024
02-28	Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	16/08/23	CI
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Visioneering Technologies, Inc. Announces Board Changes	19/12/22	CI
Visioneering Technologies, Inc. Enrolls 100% of Subjects in its International Randomized Controlled Clinical Trial Known as PROTECT	06/12/22	CI
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22	CI
Visioneering Technologies, Inc. Achieves 50% Enrollment Milestone in its PROTECT International Clinical Study for Myopia Progression Control	13/07/22	CI
Visioneering Technologies, Inc. Provides Revenue Guidance for the Year 2022	02/06/22	CI
Visioneering Technologies : Investor Presentation	21/04/22	PU
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	23/02/22	CI
Visioneering Technologies Enrolls First Patient for Contact Lens Clinical Trial; Shares Rise 3%	24/01/22	MT
Visioneering Technologies, Inc. Announces Initiation of the Protect Clinical Trial	23/01/22	CI
Visioneering Technologies, Inc. Unveils New NaturalVue Enhanced Multifocal	04/11/21	CI
Visioneering Technologies, Inc Announces the Positive Results of an Extensive, Retrospective Cohort Analysis Spanning over Six Years, on the Impact of its NaturalVue MF in Children with Myopia, or Near-Sightedness	04/11/21	CI
Visioneering Technologies, Inc. Announces US Patent Office Allows Key Patent for VTI	23/09/21	CI
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	19/08/21	CI
Benefits in a Pandemic: NaturalVue® Offers Multiple Solutions for Patients and Eye Care Practitioners	01/06/21	BU
Visioneering Technologies, Inc. Provides Revenue Guidance for the Fiscal 2021	07/04/21	CI
Visioneering Technologies : Launches Education Platform Shared Vision; Shares Slips 3%	23/11/20	MT
Visioneering Technologies, Inc. Launches Education Platform	22/11/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Visioneering Technologies, Inc.

Equities

VTI

AU000000VTI2

Highlights

Filters